NOWCHECK
LIVE

Serial Number

90058343

Owner

BIONOTE, INC.

Attorney

David D'Zurilla

Filing Date

Jul 17, 2020

Add to watchlist:

No watchlists yet
View on USPTO

NOWCHECK Trademark

Serial Number: 90058343 • Registration: 6841800

NOWCHECK is a trademark filed by BIONOTE, INC. on July 17, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

BIONOTE, INC. (19 trademarks)

22, Samsung 1-ro 4-gil, Hwaseong-si

Entity Type: 03

Trademark Details

Filing Date

July 17, 2020

Registration Date

September 13, 2022

Published for Opposition

March 29, 2022

Goods & Services

Research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids, namely, arteriosclerosis diagnostic instrument, ovulation measuring instrument, diagnostic test execution device for detecting modified abnormal prion protein, urine tester, and kidney function test equipment; Laboratory devices for detecting genetic sequences, namely, genetic tester and small miniaturized sensor for gene analysis and diagnosis, not for medical or veterinary purposes; Medical laboratory research instruments for testing genetics, namely, medical genetic test device for laboratory and scientific use, not for medical or veterinary use

Medical and veterinary biologics in the nature of biological tissue, namely, body fluids, blood, nasopharyngeal specimens, nasal specimens, saliva, conjunctival specimens, and urine specimens for medical and veterinary purposes; medical diagnostic reagents,; medical and veterinary diagnostic reagents and media, medical reagents, domestic pregnancy diagnostic agents for medical purposes, tuberculosis diagnostic reagents for medical purposes, vaccines, vaccine supplements, and bacteriological culture mediums, medical enzymes; Pregnancy test kits for home use being domestic pregnancy diagnostic agents; cell test device in the nature of medical diagnostic test kits for testing cancer cells comprised of diagnostic reagents; urine tester in the nature of medical diagnostic test kits for the analysis of urine comprised of diagnostic reagents; kidney function test equipment in the nature of medical diagnostic test kits for the analysis of body fluids comprised of diagnostic reagents; medical immunity test device in the nature of medical diagnostic test kits for the analysis of body fluids comprised of diagnostic reagents; medical immunofluorescence analysis device in the nature of medical diagnostic test kits for the analysis of body fluids comprised of diagnostic reagents; medical diagnostic immunoassay device in the nature of medical diagnostic test kits for the analysis of body fluids comprised of diagnostic reagents; diagnostic blood analysis device in the nature of medical diagnostic test kits for the analysis of various biomarkers in blood for diagnostic purposes comprised of diagnostic reagents; in vitro diagnostic device in the nature of medical diagnostic test kits for the analysis of body fluids comprised of diagnostic reagents; all of the foregoing excluding reagents and devices for use in blood glucose monitoring and diabetes care

clinical diagnostic reagents for scientific or research use, not for medical or veterinary use; domestic pregnancy diagnostic agents for scientific or research use, not for medical or veterinary use; tuberculosis diagnostic reagents for scientific or research use, not for medical or veterinary use

Medical equipment, other than for dental purposes, in the nature of medical diagnostic test instruments using chromatographic techniques for analysis of body fluid, arteriosclerosis diagnostic instrument for medical purposes, ovulation measuring instrument for medical purposes, diagnostic test execution device for detecting modified abnormal prion protein for medical purposes, bacteria and virus tester in the nature of medical diagnostic instruments for the analysis of body fluids, cell test device in the nature of medical diagnostic instruments for testing cancer cells, urine tester in the nature of medical diagnostic instruments for the analysis of urine, kidney function test equipment in the nature of medical diagnostic instruments for the analysis of body fluids, Medical measuring device for cancer diagnosis, genetic tester in the nature of Point of Care system apparatus using isothermal amplification and polymerase chain reaction technology for DNA and RNA testing for medical diagnostic purposes, small miniaturized sensor for gene analysis and diagnosis in the nature of Point of Care system apparatus for DNA and RNA testing for medical diagnostic purposes, medical immunity test device in the nature of medical diagnostic instruments for the analysis of body fluids, medical immunofluorescence analysis device in the nature of medical diagnostic instruments for the analysis of body fluids, medical genetic test device in the nature of Point of Care system apparatus for DNA and RNA testing for medical diagnostic purposes, medical diagnostic immunoassay device in the nature of medical diagnostic instruments for the analysis of body fluids, diagnostic blood analysis device in the nature of medical diagnostic instruments for the analysis of various biomarkers in blood for diagnostic purposes, in vitro diagnostic device in the nature of medical diagnostic instruments for the analysis of body fluids for medical purposes; all of the foregoing exluding instruments and devices for use in blood glucose monitoring and diabetes care

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Sep 13, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Sep 13, 2022 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Aug 7, 2022 ETOP
POST PUBLICATION AMENDMENT - ENTERED
Jun 7, 2022 CHPB
ASSIGNED TO PETITION STAFF
Jun 7, 2022 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
May 19, 2022 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Apr 28, 2022 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 29, 2022 NPUB
PUBLISHED FOR OPPOSITION
Mar 29, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 9, 2022 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Feb 23, 2022 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Feb 18, 2022 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 11, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 11, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 11, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 11, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 11, 2022 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 13, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 13, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 13, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 5, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jan 5, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jan 5, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 7, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 7, 2021 CRFA
ASSIGNED TO LIE
Dec 3, 2021 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 30, 2021 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Oct 5, 2021 GNS2
INQUIRY TO SUSPENSION E-MAILED
Oct 5, 2021 GNSI
SUSPENSION INQUIRY WRITTEN
Oct 5, 2021 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 4, 2021 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 18, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 18, 2021 GNSL
SUSPENSION LETTER WRITTEN
Mar 18, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 25, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 25, 2021 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 25, 2021 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Jan 21, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Jan 21, 2021 GNSL
SUSPENSION LETTER WRITTEN
Jan 21, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 12, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 11, 2021 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 11, 2021 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 15, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 15, 2020 GNSL
SUSPENSION LETTER WRITTEN
Dec 15, 2020 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 2, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 2, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 2, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 3, 2020 GNRN
NON-FINAL ACTION E-MAILED
Nov 3, 2020 GNRT
NON-FINAL ACTION WRITTEN
Nov 3, 2020 CNRT
ASSIGNED TO EXAMINER
Oct 30, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 14, 2020 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 13, 2020 NWOS
NEW APPLICATION ENTERED
Jul 21, 2020 NWAP